Zhejiang Shenghua Biok Biology Co., Ltd. (Shenghua Biok) announced that it made revenue of USD145.7 million and net profit of USD34.1 million in 2016, respectively down by 0.46% and up by 68.4% YoY.

On 20 May, 2016, Zhejiang Shenghua Biok Biology Co., Ltd. (Shenghua Biok) announced the conditional approval made by the China Securities Regulatory Commission on its proposal to acquire Blaze.Loong Group (Blaze.Loong). Accordingly, Shenghua Biok planned to invest USD244.4 million (USD122.2 million in cash + USD122.2 million by share) in acquiring 100% of stake in Blaze.Loong, an online game developer and distributor (as an agent), and to make a private placement targeted at the actual controlling shareholder, Shen Peijin, for a sum of <=USD229.2 million.

Zhejiang Shenghua Biok Biology Co., Ltd. (Shenghua Biok) earned a decreased revenue but an increasing net profit in 2015, according to its 2015 annual report released recently. Specifically, the company’s revenue fell by 24.8% to USD156.2 million year on year, while its net profit reached USD21.6 million, a 68.7% increase over last year.

At the end of November 2015, Zhejiang Shenghua Biok Biology Co., Ltd. (Shenghua Biok, a Chinese pesticide producer mainly engaged in dicamba and abamectin) announced the plan to transfer its 100% of shares in Inner Mongolia Biok Biology Co., Ltd. (Inner Mongolia Biok) to Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. (Shengxue Dacheng), for USD11.8 million.